These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 12018795

  • 1. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 May 10; 51(18):392-4. PubMed ID: 12018795
    [Abstract] [Full Text] [Related]

  • 2. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Dec 19; 57(50):1353-5. PubMed ID: 19092758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of penicillin-resistant Streptococcus pneumoniae--Connecticut, 1992-1993.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Apr 01; 43(12):216-7, 223. PubMed ID: 8127327
    [Abstract] [Full Text] [Related]

  • 5. From the Centers for Disease Control and Prevention. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    JAMA; 2002 Jun 19; 287(23):3071-3. PubMed ID: 12075620
    [No Abstract] [Full Text] [Related]

  • 6. Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States.
    Counts JM, Astles JR, Tenover FC, Hindler J.
    J Clin Microbiol; 2007 Jul 19; 45(7):2230-4. PubMed ID: 17522281
    [Abstract] [Full Text] [Related]

  • 7. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2004 Feb 27; 53(7):152-4. PubMed ID: 14985653
    [Abstract] [Full Text] [Related]

  • 8. Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital.
    Doğan O, Gülmez D, Hasçelik G.
    Microb Drug Resist; 2010 Mar 27; 16(1):39-41. PubMed ID: 19916790
    [Abstract] [Full Text] [Related]

  • 9. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb 27; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 10. Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001).
    Oteo J, Campos J, Cruchaga S, Baquero G, Lázaro E, Madurga M, de Abajo FJ, Baquero F, Spanish EARSS Group.
    Clin Microbiol Infect; 2004 Sep 27; 10(9):851-4. PubMed ID: 15355420
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratories.
    Edson DC, Glick T, Massey LD.
    Diagn Microbiol Infect Dis; 2006 Jul 27; 55(3):225-30. PubMed ID: 16545934
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S, Fritsche TR, Sader HS, Stilwell MG, Jones RN.
    Int J Antimicrob Agents; 2005 Apr 27; 25(4):282-9. PubMed ID: 15784306
    [Abstract] [Full Text] [Related]

  • 13. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ, Jenkins SG.
    J Antimicrob Chemother; 2004 Aug 27; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
    Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, Beekmann S.
    Clin Infect Dis; 2005 Jul 15; 41(2):139-48. PubMed ID: 15983908
    [Abstract] [Full Text] [Related]

  • 15. Comparison of susceptibility test methods to detect penicillin susceptibility in Streptococcus pneumoniae isolates.
    Mohd Nasir MD, Parasakthi N.
    Malays J Pathol; 2004 Jun 15; 26(1):29-33. PubMed ID: 16190104
    [Abstract] [Full Text] [Related]

  • 16. [No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients].
    Stephan C, Just-Nübling G, Franck S, Bickel M, Shah PM, Babacan E, Staszewski S.
    Med Klin (Munich); 2008 Feb 15; 103(2):69-74. PubMed ID: 18270662
    [Abstract] [Full Text] [Related]

  • 17. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP, Zhanel GG.
    Semin Respir Crit Care Med; 2009 Apr 15; 30(2):210-38. PubMed ID: 19296420
    [Abstract] [Full Text] [Related]

  • 18. Laboratory capacity to detect antimicrobial resistance, 1998.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Jan 07; 48(51-52):1167-71. PubMed ID: 11266245
    [Abstract] [Full Text] [Related]

  • 19. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.
    Weinstein MP, Klugman KP, Jones RN.
    Clin Infect Dis; 2009 Jun 01; 48(11):1596-600. PubMed ID: 19400744
    [Abstract] [Full Text] [Related]

  • 20. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
    Jones RN, Sader HS, Fritsche TR.
    Diagn Microbiol Infect Dis; 2004 Jun 01; 49(2):147-9. PubMed ID: 15183865
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.